ATE414906T1 - Verfahren zur identifizierung von an das chaperonin cct bindenden substanzen - Google Patents

Verfahren zur identifizierung von an das chaperonin cct bindenden substanzen

Info

Publication number
ATE414906T1
ATE414906T1 AT98922942T AT98922942T ATE414906T1 AT E414906 T1 ATE414906 T1 AT E414906T1 AT 98922942 T AT98922942 T AT 98922942T AT 98922942 T AT98922942 T AT 98922942T AT E414906 T1 ATE414906 T1 AT E414906T1
Authority
AT
Austria
Prior art keywords
cct
binding
present
chaperonine
effecting
Prior art date
Application number
AT98922942T
Other languages
English (en)
Inventor
Keith Willison
Gillian Hynes
Anthony Liou
Original Assignee
Cancer Res Inst Royal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cancer Res Inst Royal filed Critical Cancer Res Inst Royal
Application granted granted Critical
Publication of ATE414906T1 publication Critical patent/ATE414906T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
AT98922942T 1997-05-23 1998-05-22 Verfahren zur identifizierung von an das chaperonin cct bindenden substanzen ATE414906T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9710762.7A GB9710762D0 (en) 1997-05-23 1997-05-23 Binding complexes

Publications (1)

Publication Number Publication Date
ATE414906T1 true ATE414906T1 (de) 2008-12-15

Family

ID=10813018

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98922942T ATE414906T1 (de) 1997-05-23 1998-05-22 Verfahren zur identifizierung von an das chaperonin cct bindenden substanzen

Country Status (8)

Country Link
US (1) US7018791B1 (de)
EP (1) EP0983512B1 (de)
AT (1) ATE414906T1 (de)
AU (1) AU7540298A (de)
CA (1) CA2294120A1 (de)
DE (1) DE69840233D1 (de)
GB (1) GB9710762D0 (de)
WO (1) WO1998053322A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG185137A1 (en) * 2001-07-13 2012-11-29 Cms Peptides Patent Holding Company Ltd Biologically active peptides
US7125678B2 (en) * 2001-11-23 2006-10-24 Nanogen, Inc. Protein biopolymer markers predictive of type II diabetes
JP2008504006A (ja) * 2003-12-19 2008-02-14 エイジェンシー フォー サイエンス， テクノロジー アンド リサーチ タンパク質分離装置
TWI353252B (en) * 2004-04-28 2011-12-01 Cms Peptides Patent Holding Company Ltd Biologically active peptide vapeehptllteaplnpk der
US8758999B2 (en) * 2010-03-26 2014-06-24 University Of Saskatchewan Methods and compositions for the detection and identification of archaea based on the type II chaperonin (thermosome) gene
GB201520568D0 (en) 2015-11-23 2016-01-06 Immunocore Ltd Peptides
GB201520550D0 (en) 2015-11-23 2016-01-06 Immunocore Ltd & Adaptimmune Ltd Peptides
US11028138B2 (en) * 2016-07-02 2021-06-08 Virongy L.L.C. Compositions and methods for using actin-based peptides to modulate cellular bioactivity and cellular susceptibility to intracellular pathogens
CN110698540B (zh) * 2019-09-19 2021-06-25 厦门大学 乌鳢蛋白来源的ace抑制肽及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993025681A1 (en) 1992-06-11 1993-12-23 New York University A cytoplasmic chaperonin and methods of making and using it
GB2270076A (en) 1992-08-18 1994-03-02 Univ Manchester Human HSP 90 Epitopes
WO1995006662A1 (en) * 1993-09-01 1995-03-09 Start Technology Partnership Neuron regulatory factor for promoting neuron survival
AU1541395A (en) 1994-01-31 1995-08-15 Institute Of Cancer Research, The Folding proteins
WO1998013496A1 (en) 1996-09-26 1998-04-02 Medical Research Council Chaperone fragments
AU1036397A (en) 1996-12-03 1998-06-29 Medical Research Council Chaperone fragments

Also Published As

Publication number Publication date
US7018791B1 (en) 2006-03-28
EP0983512B1 (de) 2008-11-19
DE69840233D1 (de) 2009-01-02
CA2294120A1 (en) 1998-11-26
GB9710762D0 (en) 1997-07-23
WO1998053322A1 (en) 1998-11-26
EP0983512A1 (de) 2000-03-08
AU7540298A (en) 1998-12-11

Similar Documents

Publication Publication Date Title
DE69815085D1 (de) System und verfahren zur klassifizierrung von zellproben
DE69940198D1 (de) Mikrovorrichtung zum screening von biomolekülen
DE69813158D1 (de) Assays zur Bestimmung von Proteinfragmenten in biologischen Medien
DE69938867D1 (de) Verfahren und verwendung von anordungen von proteinfixierungsmitteln
DE69819332D1 (de) VERBESSERTE ANTIKÖRPER GEGEN IgE UND VERFAHREN ZUR VERBESSERUNG VON ANTIKÖRPERN
EP1029210A4 (de) Schnelltrocknungsofen und verfahren zur schnelltrocknung von mehrfachproben
ATE338951T1 (de) Vorrichtung zur automatischen durchführung von laboratoriumprüfungen
EP1025204A4 (de) Methoden und materialien zur kultivierung von von primaten abgeleiteten primordialen stammzellen
DE69800630D1 (de) Chip zur elektroforetischen Trennung von Molekülen und Verfahren zur Verwendung desselben
DE59510976D1 (de) Verfahren zur isolierung von zellinhaltsstoffen, wie nucleinsäuren, aus natürlichen quellen
DE69837544D1 (de) Testgerät und methode zur entdeckung von analyten in proben
NO20014584L (no) Proteinisolering og -analyse
ATE261127T1 (de) Vorrichtung und verfahren zur bestimmung von proteindomänegrenzen
ATE414906T1 (de) Verfahren zur identifizierung von an das chaperonin cct bindenden substanzen
ATE311443T1 (de) Methoden zur durchforstung (screenen) von proteinen
EP0871645A4 (de) Vorrichtung und verfahren zur geteilten behandlung von abwasser
ATE239274T1 (de) Proteom-analyse zum charakterisieren von auf- und abgeregelten proteinen in biologischen proben
WO2003085374A3 (en) Multiplexed assays using electrophoretically separated molecular tags
DE69823372D1 (de) Verfahren und reagentiensatz zur amplifizierung, sequenzierung und typisierung von hla i genen
DE60021960D1 (de) Verfahren zur Kompensation von Neigung und/oder Defokussierung, und Vorrichtung für dasselbige
EA200100160A1 (ru) Новые способы идентификации биомолекул лигандов и мишеней
ATE186575T1 (de) Verfahren zur identifizierung von menschlichen und tierischen zellen mit der fähigkeit zu unbegrenzter proliferation oder zur tumorbildung
WO2002048403A3 (en) Multiplexed protein expression and activity assay
ATE191568T1 (de) Spezifische bindungssubstanzen für antikörper und deren verwendung für immunoassays oder vakzine
Maier et al. Primary structure of yeast proteinase B inhibitor 2.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties